NCT06381895View on ClinicalTrials.gov

The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer

CompletedOBSERVATIONAL

Enrollment

1,200

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

February 20, 2024

Conditions

Bladder CancerRadiomicsImmunotherapy

Trial Locations (1)

Unknown

Sun Yat-sen Memorial Hospital, Guangzhou

All Listed Sponsors

lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER